Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro

British Journal of Urology

Volumn 79, Issue 6, 1997, Pages 958-963

  Jeremy, J Y ^a,b,c,d   Ballard, S A ^a   Naylor, A M ^a   Miller, M A W ^a   Angelini, G D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Erectile dysfunction; Nitric oxide; Penis; Phosphodiesterase type 5; Sildenafil

Indexed keywords

CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PAPAVERINE; SILDENAFIL;

ANIMAL TISSUE; ARTICLE; CORPUS CAVERNOSUM; DRUG MECHANISM; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY;

EID: 0031403328     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00206.x     Document Type: Article

References (22)

1. Finberg JPM, Levy S, Vardi Y. Inhibition of nerve stimulation-induced vasodilation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase. Br J Pharmacol 1993; 108: 1038-42
2. Azadzoi KM, De Tajeda IS. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1991; 146: 238-40
3. De Tajeda IS, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025-30
4. Trigo-Rocha F, Hsu GL, Donatucci CF, Lue TF. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic, neurotransmission in canine penile erection. J Urol 1993; 149: 872-7
5. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21
6. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12
7. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175-95
8. Schiavi RC, Stimmel BB, Mandeli J, Rayfield EJ. Diabetes mellitus and male sexual dysfunction: a controlled study. Diabetologia 1993; 36: 745-51
9. Miller MAW, Morgan RJ. Eicosanoids, erections and erectile dysfunction. Prostagl Leukotr Essential Fatty Acids 1994; 51: 1-9
10. Mikhailidis DP, Jeremy JY. Smoking and impotence. Int Angiol 1994; 12: 297-8
11. Boolell M. Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-61
12. Boolell M, Allen MJ, Ballard SA et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52
13. Gingell CJC, Jardin A, Olsson AM et al. UK-92,480 a new oral therapy for erectile dysfunction, a double blind placebo controlled, once daily dose response study (abstr). J Urol 1996; 155: 738
14. Eardley I, Morgan RJ, Dinsmore WW, Pearson J, Wulff MB, Boolell M. UK-92480 a new oral therapy for erectile dysfunction, a double-blind placebo controlled trial with treatment taken as required (abstr). J Urol 1996; 155: 737
15. Ballard SA, Turner LA, Naylor AM. Sildenafil, a potent selective inhibitor of type 5 phosphodiesterase enhances nitric oxide-dependent relaxation of rabbit corpus cavernosum (abstr). Br J Pharmacol 1996: 118: 153P
16. Tang K, Turner LA, Ballard SA, Naylor AM. Effects of a novel phosphodiesterase type 5 inhibitor, sildenafil, on methacholine induced relaxation of isolated rabbit corpus cavernosum (abstr). Br J Pharmacol 1996: 118; 154P
17. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982; ii: 938
18. Miller MAW, Morgan RJ, Thompson CS, Mikhailidis DP, Jeremy JY. Effects of papaverine and vasointestinal polypeptide on penile and vascular cAMP and cGMP in control and diabetic animals : an in vitro study. Int J Impot Res 1995; 7: 91-100
19. Miller MAW, Morgan RJ, Thompson CS, Mikhailidis DP, Jeremy JY. Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: an in vitro study. Br J Urol 1994; 74: 106-11
20. Freelisch M, Noack E. Correlation between nitric acid formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30
21. Beavo, JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990: 11: 150-5
22. Huddart H, Langton P, Saad KHM. Inhibition by papaverine of calcium movements and tension in the smooth muscle of rat vas deferens and urinary bladder. J Physiol 1984; 349: 189-94